VARS2 V552V variant as prognostic marker in patients with early breast cancer.
The present study analyzed the polymorphisms of DNA repair genes and their impact on the survival of 240 patients with early breast cancer. The genomic DNA was extracted from paraffin-embedded tumor-free tissue or blood, and thirteen polymorphisms in 12 DNA repair genes were determined using the Sequenom Mass array system. Among the target polymorphisms, VARS2 rs2074511 and POLE rs5744857 were found to correlate with survival after curative surgery in a log-rank test. No difference was found in the clinical and tumor characteristics according to the genotypes of these two coding variants, except for a higher incidence of positive ER in patients with the GG genotype of POLE rs5744857 (P=0.025). Meanwhile, a multivariate analysis showed that the GG genotype of VARS2 V552 V (rs2301717) was significantly associated with disease-free survival (DFS; HR=0.298; P=0.044) and marginally with distant DFS (DDFS; HR=0.266; P=0.077). In particular, the VARS2 rs2074511 polymorphism was only associated with survival in patients with triple negative (TN)-type breast cancer (P=0.018 for DFS and 0.042 for DDFS, respectively). In conclusion, VARS2 V552V may be considered as a prognostic factor for survival in patients with early breast cancer.
Chae
Yee Soo
YS
Department of Oncology/Hematology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, 50 Samduk 2-Ga, Jung-Gu, Daegu, Korea.
Lee
Soo Jung
SJ
Moon
Joon Ho
JH
Kang
Byung Woog
BW
Kim
Jong Gwang
JG
Sohn
Sang Kyun
SK
Jung
Jin Hyang
JH
Park
Ho Yong
HY
Park
Ji Young
JY
Kim
Hye Jung
HJ
Lee
Sang-Woo
SW
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics* / Q000401:mortality* / Q000473:pathology*; D004260:DNA Repair / Q000235:genetics; D018572:Disease-Free Survival; D005260:Female; D005838:Genotype; D006680:HLA Antigens / Q000235:genetics*; D006801:Humans; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis; D016016:Proportional Hazards Models; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D014637:Valine-tRNA Ligase / Q000235:genetics*; D055815:Young Adult
D014408:Biomarkers, Tumor; D006680:HLA Antigens; C070977:VARS2 protein, human; D014637:Valine-tRNA Ligase